Tissue Window versus Time Window? A Review of Patients Receiving Extended Hours Thrombolysis Guided By DWI-FLAIR Mismatch : Case Series
Main Article Content
Abstract
Introduction: Intravenous thrombolysis (IVT) is the gold standard for the treatment of patients with acute ischemic stroke (AIS) presenting within four and a half hours of onset. However, development of new thrombolytic agents and advanced imaging has led to extended time for thrombolysis based on advanced imaging. Here we describe four patients who presented in the extended hours; that benefitted from thrombolysis. Case series: We advocate magnet- ic resonance imaging (MRI) for AIS, that includes diffusion weighted imaging (DWI), apparent diffusion coefficient (ADC), fluid attenuated inversion recovery (FLAIR), susceptibility weighted imaging (SWI), and magnetic resonance angiography (MRA). We included four patients who were more than 18 years old, with National Institute of Health Stroke Scale (NIHSS) of six or more, presenting between four and a half to nine hours after stroke onset with no con- traindications for intravenous thrombolysis. The imaging criteria used to determine eligibility for IVT is evidence of DWI-FLAIR mismatch on MRI. If FLAIR detects no signal change in the area of stroke on DWI, it is then termed DWI- FLAIR mismatch, or FLAIR-negative – indicating high probability that the brain tissue is still viable, and that patients are good candidates for IVT. Conclusion: For patients with AIS who present within nine hours, DWI-FLAIR mismatch serves as an excellent surrogate marker of salvageable brain tissue, allowing a greater proportion of patients benefit- ing from this life-saving therapy. Our experience also shows that with careful patient selection, treatment with IVT can safely be given without an increased risk of bleeding or mortality.
Downloads
Article Details
References
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke A. Vol. 50. Stroke. 2019;344–418.
Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378(1): 11–21.
Yang P, Zhang Y, Zhang L, Zhang Y, Treurniet KM, Chen W, et al. Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke. N Engl J Med. 2020;382(21):1981–93.
Berge E, Whiteley W, Audebert H, De Marchis GM, Fonseca AC, Padiglioni, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6: I–LXII.
Tsivgoulis G, Katsanos AH, Malhotra K, Sarraj A, Baretto AD, Kohrmann M, et al. Thrombolysis for acute ischemic stroke in the unwitnessed or extended therapeutic time window. Neurology. 2020;94(12):e1241–8.
Wang D and Wang Y. Tissue window, not the time window, will guide acute stroke treatment. Stroke Vasc Neurol. 2019;4(1):1–2.
Mackey J, Kleindorfer D, Sucharew H, Moomaw CJ, Kissela BM, Alwell K, et al. Population- based study of wake-up strokes. Neurology. 2011;76(19):1662–7.
Kim BJ, Kim HJ, Lee DH, Kwon SU, Kim SJ, Kim JS, et al. Diffusion-weighted image and fluid- attenuated inversion recovery image mismatch unclear-onset versus clear-onset stroke. Stroke. 2014;45(2):450–5.
Inoue M and Toyoda K. Expanding the therapeutic window in acute ischemic stroke by advanced imaging. Vessel Plus. 2021; 5: 11.
Pfaff JAR, Bendszus M, Donnan G, Molina C, Leys D, Schellinger PD, et al. The impact of the DWI- FLAIR-mismatch in the ECASS-4 trial – A post hoc analysis. Eur Stroke J. 2020;5(4):370–3.
Kanekar SG, Zacharia T and Roller R. Imaging of stroke: Part 2, pathophysiology at the molecular and cellular levels and corresponding imaging changes. Am J Roentgenol. 2012;198(1):63–74.
Wouters A, Dupont P, Christensen S, Norrving B, Laage R, Thomalla G, et al. Association between time from stroke onset and FLAIR lesion intensity is modified by status of collateral circulation. Stroke. 2017;46(5):1247–62.
Jakubicek S, Krebs S, Posekany A, Ferrari J, Szabo J, Siarnik P, et al. Modified DWI-FLAIR mismatch guided thrombolysis in unknown onset stroke. J Thromb Thrombolysis. 2019;47(2):167–73.
Aoki J, Sakamoto Y, Suzuki K, Nishi Y, Kutsuna A, Takei Y, et al. Fluid-Attenuated Inversion Recovery May Serve As a Tissue Clock in Patients Treated With Endovascular Thrombectomy. Stroke. 2021;52(7):2232–40.
Wang Y, Zhou Z and Ding S. FLAIR vascular hyperintensity-DWI mismatch most likely to benefit from recanalization and good outcome after stroke. Med. 2020;99:2.
Odland A, Særvoll P, Advani R, Kurz MW and Kurz KD. Are the current MRI criteria using the DWI- FLAIR mismatch concept for selection of patients with wake-up stroke to thrombolysis excluding too many patients? Scand J Trauma Resusc Emerg Med. 2015;23(1):1–6.
Huisa BN, Liebeskind DS, Raman R, Hao Q, Meyer BC, Meyer DM, et al. DWI – FLAIR Mismatch in Nocturnal Strokes Patients with Unknown Time of Onset. J Stroke Cerebrovasc Dis. 2013;22(7):972– 977.
Warach SJ, Dula AN and Milling TJ. Tenecteplase thrombolysis for acute ischemic stroke. Stroke. 2020;11:3440–51.
Modi NB, Fox NL, Clow FW, Tanswell P, Cannon CP, Van de Werf F, Braunwald E. Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction. J Clin Pharmacol. 2000; 40(5):508-15.
Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Yan B, et al. Tenecteplase versus alteplase before endovascular thrombectomy (EXTEND-IA TNK): A multicenter, randomized, controlled study. Int J Stroke. 2018;13(3):328–34.